Inflammatory Mediator Response as a Potential Risk Marker for Periodontal Diseases in Insulin-Dependent Diabetes Mellitus Patients

Journal of Periodontology

Volumn 68, Issue 2, 1997, Pages 127-135

  Salvi, Giovanni E ^a,b,c   Yalda, Behnaz ^a   Collins, John G ^a   Jones, Bettye H ^a   Smith, Frances W ^a   Arnold, Roland R ^a   Offenbacher, Steven ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Diabetes mellitus; Gingival crevicular fluid analysis; Interleukin 1 ; Prostaglandin E2

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; FEMALE; GINGIVITIS; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; NONPARAMETRIC TEST; PERIODONTAL DISEASE; RISK;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DINOPROSTONE; FEMALE; GINGIVAL CREVICULAR FLUID; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; PERIODONTAL DISEASES; RISK; STATISTICS, NONPARAMETRIC;

EID: 0031068551     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1997.68.2.127     Document Type: Article

References (51)

1. Katz PP, Wirthlin MR Jr, Szpunar SM, Selby JV, Sepe SJ, Showstack JA. Epidemiology and prevention of periodontal disease in individuals with diabetes. Diabetes Care 1991;14:375-385.
2. Yalda B, Offenbacher S, Collins JG. Diabetes as a modifier of periodontal disease expression. Periodontol 2000 1994;6:37-49.
3. Slots J. Bacterial specificity in adult periodontitis. A summary of recent work. J Clin Periodontol 1986;13:912-917.
4. Haber J, Wattes J, Crowley R. Assessment of diabetes as a risk factor for periodontitis. J Dent Res 1991;70(Spec. Issue):414(Abstr. 1187).
5. Grossi SG, Zambon JJ, Norderyd CM, et al. Microbiological risk indicators for periodontal disease. J Dent Res 1993;72(Spec. Issue): 206(Abstr. 818).
6. Broadley KN, Aquino AM, Hicks B, et al. The diabetic rat as an impaired wound healing model: stimulatory effects of transforming growth factor-beta and basic fibroblast growth factor. Biotechnol-Ther 1989-90;1:55-68.
7. Hove KA, Stallard RE. Diabetes and the periodontal patient. J Periodontol 1970;41:713-718.
8. Lamey PJ, Darwazeh AMG, Fisher BM. Oral disorders associated with diabetes mellitus. Diabet Med 1992;9:410-416.
9. Cutler CW, Eke P, Arnold RR, Van Dyke TE. Defective neutrophil function in an insulin-dependent diabetic patient. A case report. J Periodontol 1991;62:394-401.
10. Manoucher-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol 1981;52:410-414.
11. Van Dyke TE, Horoszewicz HU, Cianciola LJ, Genco RJ. Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun 1980;27:124-132.
12. Lavine WS, Maderaso EG, Stolman J, et al. Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressive periodontitis. J Periodont Res 1979;14:10-19.
13. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994;14:1521-1528.
14. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products, J Lab Clin Med 1994;124: 19-30.
15. Brownlee M. Glycation and diabetic complications. Diabetes 1994;43:836-841.
16. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycation end products of proteins. J Biol Chem 1992;267:14998-15004.
17. Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994;269:9889-9897.
18. Dyer D, Dunn J, Thorpe S, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 1993;91:2463-2469.
19. McCance D, Dyer D, Dunn J, et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993;91:2470-2478.
20. Yu Z, Ramamurthy NS, Leung M, Chang KM, McNamara TF, Golub LM. Chemically-modified tetracycline normalizes collagen metabolism in diabetic rats: a dose-response study. J Periodont Res 1993;28:420-428.
21. Mølvig J. A model of the pathogenesis of insulin-dependent diabetes mellitus. Dan Med Bull 1992;39:509-541.
22. Nerup J, Mandrup-Poulsen T, Mølvig J. The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. Diabetes Metab Rev 1987;3:779-802.
23. Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup J. A Taq 1 polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1991;22:396-402.
24. Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. J Immunol 1989;143:913-922.
25. 2 shows stable interindividual differences. Scand J Immunol 1988;27:706-716.
26. Todd JA. Genetic control of autoimmunity in type 1 diabetes. Immunol Today 1990;11:122-129.
27. Leslie RDG, Lazarus NR, Vergani D. Etiology of insulin dependent diabetes mellitus. Br Med Bull 1989;45:58-72.
28. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNFα promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-511.
29. Cabrera M, Shaw MA, Sharples C, et al. Polymorphism in TNF genes associated with mucocutaneous leishmaniasis. J Exp Med 1995;182:1259-1264.
30. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986;21:101-112.
31. Massada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-1α and -1β in gingival crevicular fluid: Implications for the pathogenesis of periodontal disease. J Periodont Res 1990;24:156-163.
32. 2 in crevicular fluid. J Clin Periodontol 1981;8:359-367.
33. Brunk CF, Jones KC, James T. Assay for nanogram quantities of NDA in cellular homogenates. Analytic Biochem 1979;92:497-500.
34. Kasper DL. Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis 1976;134:59-66.
35. Offenbacher S, Collins JG, Yalda B, Haradon G. Role of prostaglandins in high risk periodontitis patients. In: Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, eds. Molecular Pathogenesis of Periodontal Disease. Washington DC: ASM Press; 1994;203-214.
36. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNFα secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997 (in press).
37. Mandell RL, DiRienzo J, Kent R, Joshipura K, Haber J. Microbiology of healthy and diseased periodontal sites in poorly-controlled insulin-dependent diabetics. J Periodontol 1992;63:274-279.
38. Zambon JJ, Reynolds H, Fisher JG, Shlossman M, Dunford R, Genco RJ. Microbiological and immunological studies of adult periodontitis in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1988;59:23-31.
39. Barnett ML, Baker RL, Yancey JM, MacMillan DR, Kotoyan M. Absence of periodontitis in a population of insulin-dependent diabetes mellitus patients. J Periodontol 1984;55:402-405.
40. Sastrowijoto SH, van der Velden U, van Steenhergen TJ, et al. Improved metabolic control, clinical periodontal status and subgingival microbiology in insulin-dependent diabetes mellitus. A prospective study. J Clin Periodontol 1990;17:233-242.
41. De Pommereau V, Dargent PC, Robert JJ, Brion M. Periodontal status in insulin-dependent diabetic adolescents. J Clin Periodontol 1992;19:628-632.
42. Burmeister JA, Best AM, Palcanis KG, Caine FA, Ranney RR. Localized juvenile periodontitis and generalized severe periodontitis. Clinical findings. J Clin Periodontol 1981;11:181-192.
43. Vlassara H, Brownlee M, Manogue K, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins:role in normal tissue remodeling. Science 1988;240:1546-1548.
44. Pociot F, Mølvig J, Wogensen L, et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991;33:37-49.
45. Luger A, Schernthaner G, Urbanski A, Luger TA. Cytokine production in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus. Eur J Clin Invest 1988;18:233-236.
46. Mølvig J, Pociot F, Baek L, et al. Monocyte function in IDDM patients and healthy individuals. Scand J Immunol 1990;32:297-311.
47. Tovo PA, Cerutti F, Palomba E, Salomone C, Pugliese A. Evidence of circulating interferon-γ in newly diagnosed diabetic children. Acta Ped Scand 1984;73:785-788.
48. Scuderi F, Muscettola M, DiLeo MAS, et al. High levels of serum interferon-gamma do not decrease with cyclosporin treatment in type 1 (insulin-dependent) diabetes. Dianbetologia 1989;32:540A(Abstr. 454).
49. Lorini R, Montagna D, Lanfranchi A. Alterations of in vitro interleukin 1 and 2 in diabetic children. Eur J Pediatr 1989;148:732-734.
50. Hussain MJ, Peakman M, Leslie RDG, Viberti GC, Watkins PJ, Vergani D. Circulating levels of interleukin- 1α, tumour necrosis factor-α and interferon-γ are high in newly-diagnosed type 1 diabetes. Diabetologia 1990;33(Suppl.):A25(Abstr. 55).
51. Prabhu A, Michalowicz BS, Mathur A. Detection of local and systemic cytokines in adult periodontitis. J Periodontol 1996;67:515-522.